| 产品详情 |
| Edit |   |
|---|
| Product Name | DRAK2, CT, Blocking Peptide (DAP Kinase-related Apoptosis-inducing Protein Kinase 2) |
|---|
| Description | Purified 60-70%. Peptide corresponding to amino acids 351 to 365 of human DRAK2 (1). Apoptosis is mediated by death domain containing adapter molecules and a caspase family of proteases. Certain serine/threonine protein kinases, such as ASK-1 and RIP, are mediators of apoptosis. Two novel serine/threonine kinases that induce apoptosis were recently identified and designated DRAK1 and DRAK2 (for DAP kinase-related apoptosis-inducing protein kinases) (1). DRAKs contain an N-terminal kinase domain and a C-terminal regulation domain. Overexpression of DRAK2 induces apoptosis. DRAKs have high sequence homology to DAP and ZIP kinases, and they represent a novel family of serine/threonine kinases, which mediates apoptosis through their catalytic activities. DRAK2 is located in nucleus and the messenger RNA was ubiquitously expressed in human tissues (1). |
|---|
| Size | 50ug |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | D9335P |
|---|
| Price | |
|---|
| Order / More Info | DRAK2, CT, Blocking Peptide (DAP Kinase-related Apoptosis-inducing Protein Kinase 2) from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|